Exelixis
EXEL
#1721
Rank
A$17.58 B
Marketcap
A$69.98
Share price
-0.40%
Change (1 day)
6.05%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company